You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Jacob Uno Stanley Gunterberg

Partner at Healthcap Advisor AB
Overview
Relationships
Paths
Education
Career History
Boards & Committees

Jacob Uno Stanley Gunterberg

Partner at Healthcap Advisor AB

Overview

Age
50 (Born 1967)
Notable Companies
Hjalmarsson & Partners Corporate Finance AB

Hjalmarsson & Gunterberg Corporate Finance AB
Board Seats
22
Number of Relationships
This person is connected to 166 people.

Relationships See Details


Founding Partner at HealthCap AB

Founding Partner at HealthCap AB

Founding Partner at HealthCap AB

Founding Partner at HealthCap AB

Partner at HealthCap AB

Partner at Tellacq AB

Chief Technology Officer at MIPS AB

Director & Chief Technology Officer at Revent Medical, Inc.

Former Partner at Advokatfirman Vinge KB

Chief Executive Officer at Medical Need Europe AB
See 156 more listings with RelSci Professional.

Paths to Jacob Uno Stanley Gunterberg

Jacob Uno Stanley Gunterberg
You
Connections via Relationship Science
Jacob Uno Stanley Gunterberg
Sync your contacts to see how you can connect with Jacob Uno Stanley Gunterberg.

Educational Background

Master of Science in Business Administration & Economics 
Lund University is one of northern Europe's oldest and most prestigious universities.
Attendee 
The University of St. Gallen is a research university located in St. Gallen, Switzerland. Established in 1898, it is specialized in the fields of business administration, economics, law, and international affairs The University of St. Gallen is also known as HSG, which is an abbreviation of its former German name Handels-Hochschule St. Gallen.

Career History

Partner
Current
HealthCap Advisor AB is a Swedish private company located in Stockholm. The firm provides investment advice.
Partner
2007 - 2015
Healthcap is an active, long-term manager which invests in pharmaceutical, biotechnology and medical technology companies globally. As a multi-stage fund, the firm provides and participates in financing through all stages of company evolution. Their funds have no geographic restrictions.Healthcap's main investment style is to be lead investor and the firm acts predominantly as an influential minority investor, seeking to invest in the commercialization of innovations in medical science where they believe that the structural changes taking place in the pharmaceutical industry create significant opportunities for knowledgeable investors to achieve high financial returns.The firm partners with investee companies and founders, seeking board representation to assist with strategy formulation in the areas of science, business development and finance. They encourage substantial ownership by entrepreneurs and scientific founders and insist on implementing employee equity ownership programs to attract and reward key personnel.Healthcap's in-house science team evaluates the scientific merits of investment proposals and their in-house transaction team structures the transactions. The firm invests independently or in partnership with other investor groups.
Co-Founder
2000 - 2007
Hjalmarsson & Partners Corporate Finance AB provides financial advisory services. It specializes in mergers, acquisitions, and equity capital raisings. The company was founded by UIf Hjalmarsson in 2000 and is headquartered in Stockholm, Sweden.
Co-Founder
2000 - Prior
Director-Life Sciences Sector
1997 - Prior
Aros Securities AB is a Swedish private company located in Stockholm that provides securities related services.
Director, Life Sciences Sector
1993 - Prior

Boards & Committees

Corporate Boards ▾
Independent Director
2008 - Current
MIPS AB engages in the manufacture of helmet for reducing rotational forces on the brain caused by angled impacts to the head. It offers motorcycle, equestrian, snow and ski, bicycle, and American football helmets. The company was founded by Stale Moller, Per Evert Niklas Steenberg, Hans Von Holst, Hans Peter Halldin, and Magnus Aare in 2001 and is headquartered in Täby, Sweden.
Chairman
Current
Member, Board of Directors
Current
MIPS Technologies, Inc. provides industry-standard processor architectures and cores for home entertainment, networking, mobile and embedded applications. The company was founded in June 1992 and is headquartered in Sunnyvale, CA.
Deputy Board Member
Current
BONESUPPORT HOLDING AB is a commercial stage orthobiologics company, which develops and commercializes innovative injectable bioceramic bone graft substitutes to treat bone voids. Its product CERAMENT is a synthetic bone graft substitute that is a mixed form of an injectable paste. It is used to fill gaps or voids in bone to promote bone healing. The company's products include; CERAMENT BVF, CERAMENT G, and CERAMENT V all are based on the novel and proprietary CERAMENT technology platform. BONESUPPORT HOLDING was founded by Lars Åke Alvar Lidgren and Fredrik Lindberg in 1999 and is headquartered in Lund, Sweden.
Director
Current
Revent Medical, Inc. develops cost effective and innovative medical implants for patients with obstructive sleep apnea. The company was founded by Edward M. Gillis in 2008 and is headquartered in Newark, CA.
Member, Board of Directors
Current
Director
Current
Director
Current
Director
Current
Director
Current
Board Observer
Current
Technolas Perfect Vision GmbH develops and markets laser and surgical technology solutions. Its brands include TENEO 317 Laser, VICTUS Femtosecond Laser, ZYOPTIX Diagnostic Workstation, and ZYOPTIX Microkeratome. The company was founded in 2009 and is headquartered in Munich, Germany.
Board Observer
Current
LTB4 Sweden AB engages in research and product development related to antimicrobial and anti-inflammatory substances through its subsidiaries. The company was founded by Bengt Ingemar Samuelsson on February 26, 2004 and is headquartered in Stockholm, Sweden.
Director
Prior - 2017
OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm’s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.
Director
Prior
Newron Sweden AB is engaged in therapeutic drug development. It focuses on neurogenesis for the treatment of neurodegenerative diseases such as Parkinson's and Alzheimer's diseases, amyotrophic lateral sclerosis, and Huntington's disease. The firm uses its integrated platform of drug discovery technologies to identify drug targets and existing drugs that can stimulate the formation of new neurons in the brain. The company was founded by Jonas Frisen and Ann Marie Janson Lang in 1998 and is headquartered in Stockholm, Sweden.
Director
Prior
Immune Targeting Systems (ITS) Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom.
Deputy Director
Prior
Wilson Therapeutics AB operates as a biopharmaceutical company that develops novel therapies for patients with rare genetic disorder of impaired copper metabolism that causes serious copper poisoning. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden.
Director
Prior
Trimb Healthcare AB develops and sells Over-the-Counter pharmaceutical and consumer healthcare products. Its brands include Betavivo, Poxclin, Dexem, Propyless, Footner, Hemoclin, Clinomyn, Nailner, Nozoil, Red-I, Spotner, Nozovent, and Wortie. The company was founded in 2012 and is headquartered in Stockholm, Sweden.
Director
Prior
Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development.
Director
Prior
Director
Prior
Director
Prior
Director
Tenure Unconfirmed
Healthcap VI LP invests in the commercialization of innovations in medical sciences. The fund focuses on companies operating in the fields of pharmaceutical, biotechnology and medical technology. It invests globally and provides financing for seed, early and later stage capital requirements.

Other Affiliations

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial
Still not convinced? Check out our full listing of features here.